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Background: Type 2 diabetes mellitus is a multi-factorial disease in which both genetic and non-genetic factors
interact in order to precipitate the diabetic phenotype. Among various predisposing genetic loci, a pentanucleotide
(CTTTA) Del/Ins variant in the 3'-UTR of the LEPR gene is associated with type 2 diabetes and its related traits. This
study was done to explicate for the first time the association of this Del/Ins polymorphism of LEPR gene in type 2
diabetes patients belonging to the ethnic population of Kashmir valley.
Methods: 670 unrelated subjects comprising of 320 type 2 diabetes patients and 350 healthy controls were
included in the study. Genotyping of the untranslated region of LEPR gene encompassing this Del/Ins variant was
done by PCR-RFLP technique and results were validated by direct sequencing.
Results: Genotype frequencies for both type 2 diabetes cases and healthy controls were consistent with Hardy-Weinberg
equilibrium (χ2 = 3.09 and 2.37, P =NS). The Del/Del genotype was predominantly found in cases than controls (P = 0.003,
OR: 0.62, CI: 0.45-0.85). Carriers of Ins/Ins genotype were relatively protected against the risk factors (P = 0.0004, OR: 0.31,
95% CI: 0.15-0.61). A positive association was observed between the Del allele and the risk factors of type 2 diabetes.
Conclusion: The results elucidate that the CTTTA Del allele is a genotypic risk factor of type 2 diabetes in the Kashmiri
population.
Keywords: Polymorphism, Type 2 diabetes mellitus, Kashmir valley, Ethnic population, LEPRBackground
Type 2 Diabetes Mellitus (T2DM) is a multifarious dis-
order caused by interactions between susceptible genetic
loci and environmental slurs. T2DM is an incipient non-
communicable global epidemic [1]. The genetics of
T2DM is incoherent with respect to the patterns of simple
Mendelian inheritance. Contemporary studies inspecting
the genetic elements involved in the development of
T2DM have not identified any disease-causing mutations;
however several predisposing genetic variants (polymor-
phisms) have been recognized [2-4]. The heterogeneity of
this disorder renders the understanding of risk factors and
sequence of events obscure. Currently the involvement of* Correspondence: bbcganai@gmail.com
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unless otherwise stated.diverse proteins produced and secreted by adipocytes, col-
lectively termed as adipokines is recognized to modulate
insulin resistance [5]. Amongst these adipokines; leptin,
resistin, TNF-α and free fatty acids are implicated in con-
vening insulin resistance whereas adiponectin improves
sensitivity. Inconsistency between insulin resistant and in-
sulin sensitizing adipokines is implicated in type 2 diabetes
and related disorders. Leptin exerts its central and periph-
eral effects by binding to its receptors that belong to the
class I cytokine receptor superfamily [6]. This binding re-
sults in subsequent activation of downstream signalling
pathways regulating satiety and stimulating energy ex-
penditure [7]. Sequential phenotypic manifestations of dia-
betes like hyperinsulinemia, obesity and β-cell failure are
observed in animal models (ob/ob and db/db mice) [8,9].
Disparity between leptin-insulin alliance in pancreatic β-
cells as a result of leptin resistance in overweight patientsl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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subsequent development into T2DM [10,11]. In pancre-
atic β-cells, inhibition of insulin secretion by leptin has
been shown to be mediated by the long form of LEPR
gene [12,13]. The human leptin receptor gene (LEPR) is
localised in proximity of the microsatellite marker
D1S198 which is associated with acute insulin response
[14-16]. The 3'-UTR (untranslated region) of LEPR gene
encompasses a pentanucleotide (CTTTA) Deletion/Inser-
tion polymorphism. Studies investigating this Del/Ins poly-
morphism have shown an association with susceptibility to
type 2 diabetes and related risk factors [15,17-22]. We
screened the CTTTA-pentanucleotide Del/Ins in 3'-UTR of
LEPR gene in ethnic Kashmiri population of north India.
Our study is the first ever molecular characterization of
type 2 diabetes mellitus patients of Kashmiri valley aimed
to study a possible association between this genetic poly-
morphism and type 2 diabetes mellitus.Methods
Study population and Clinical parameters
The study included 670 ethnic Kashmiri subjects, com-
prising of 320 unrelated type 2 diabetes mellitus patients
and 350 healthy controls assenting to participate volun-
tarily. Type 2 diabetes cases were diagnosed as per
ADA/WHO criteria. Controls were matched for age and
gender. Exclusion criteria involved patients with drug
induced, stress induced and gestational diabetes. The
study was approved by institutional ethical committee
(IEC-SKIMS) and the research protocol conforms to the
provisions of the Declaration of Helsinki (as revised in
Tokyo 2004). 4 ml of blood was collected from the cu-
bital vein after 12 hours of fast from each subject.
Serum was separated from 2 ml of blood and immedi-
ately sent for biochemical analyses. Remaining 2 ml of
blood was stored in EDTA vacutainer at −70°C until
processed for isolation of DNA. Laboratory tests includ-
ing fasting plasma glucose (FPG), total cholesterol (TC),
triglycerides (TG), high density lipoprotein (HDL), low
density lipoprotein (LDL) and serum creatinine levels
were measured on an autoanalyzer.
Hypertension was defined as a systolic pressure
≥140 mmHg or diastolic pressure ≥90 mmHg. Blood
pressure (BP) was measured using standardFigure 1 Partial sequence electropherogram of 3'-UTR Del/Ins polymosphygmomanometer in the sitting position after a 10 mi-
nute rest. Anthropometric data comprised of Body Mass
Index (BMI) and Waist to Hip ratio (WHR). Height and
weight were measured using standard anthropometric
techniques in light-weight clothing without shoes.
Waist circumference was measured midway between
the lower rib margin and the iliac crest at the end of
gentle expiration using an anthropometric measuring
tape. BMI was expressed as kg/m2.
Genotyping
DNA was extracted from peripheral leukocytes by Qiamp
Blood Mini extraction kit (Qiagen Valencia, CA). The vari-
ant CTTTA pentanucleotide insertion was screened by
polymerase chain reaction (PCR) by amplifying a 114/
119 bp region of LEPR gene using 5' mismatch primer
ATAATGGGTAATATAAAGTGTAATAGAGTA and 3'
primer AGAGAACAAACAGACAACATT in a thermal
cycler (Eppendorf Hamburg, Germany). PCR cycling con-
ditions comprised of an initial denaturation for 7 min at
95°C followed by 30 repeats (30 sec each) at 95°C, 55°C
and 72°C and a final extension step of 7 min at 72°C.
Amplified products were verified by electrophoresis using
2% agarose gel. 10 μl aliquots of the amplified products
were digested overnight at 37°C with the restriction en-
zyme Rsa I (Fermentas). Digested products were resolved
on 4% agarose gel and cleavage products were visualized
by ethidium bromide staining. Deletion genotype was not
amenable to restriction digestion and resolved as a single
114 bp band whereas the Insertion genotype was digested
by Rsa I enzyme yielding 90 bp and 29 bp fragments. Het-
erozygous Insertion/Deletion genotype was characterized
by all three bands of 114 bp, 90 bp and 29 bp. Results were
further validated by direct sequencing. Purification and
Sequencing was done by Macrogen Inc.1001 World
Meridian Venture Center. The genotypic results were in
conformity with the sequencing analysis.
Statistical analyses
Data were managed by Microsoft excel and Java Stat
software. Power calculation of the study was performed
by online statistical calculator (http://osse.bii.a-star.edu.sg/
calculation2.php). The power of study measures 81.4% for
observed frequency of minor alleles at 5% significance
level. Statistical Package for Social Sciences (SPSS, versionrphism of LEPR gene (Homozygous wild Del/Del).
Figure 2 Partial sequence electropherogram of 3'-UTR Del/Ins polymorphism of LEPR gene (Homozygous variant Ins/Ins).
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as Mean ± SD and percentage. Chi-square (χ2) test and
odds ratio analysis were used for genotyping where P
value of <0.05 was considered to be significant. Hardy and
Weinberg equilibrium was determined by χ2 analysis. Inter
group variants of metric data was measured by Students t-
test at 95% confidence interval. The non-metric data was
analyzed by Mann Whitney-U test.
Results
320 unrelated subjects with type 2 diabetes mellitus and
350 healthy controls were screened for the Del/Ins poly-
morphism in 3'-UTR of the LEPR gene. The predominant
age group was 50–60 years and the mean age of cases and
controls was 50.4 ± 11.1 years and 49.2 ± 12.4 years re-
spectively. 69.5% of cases had a familial history of type 2
diabetes. 55.2% cases were shown to be hypertensive by
systemic examination. The status of disease was indicated
by HbA1c levels. HbA1c > 8% corresponded to 41% of
cases, illustrating uncontrolled diabetes state and im-
proper management of disease in such subjects. Mo-
lecular characterization of 3'-UTR of the LEPR gene by
PCR-RFLP revealed three genotypes (Del/Del, Del/Ins
and Ins/Ins) in our population (Figures 1, 2 and 3). Geno-
types were in Hardy Weinberg equilibrium for both cases
(χ2 = 3.03, P =Non Sig) and controls (χ2 = 2.16, P =Non
Sig). The homozygous Del/Del genotype was present in
55.6% of cases and 41.7% of controls. 40.4% of cases and
48.6% of controls exhibited the Del/Ins genotype (Table 1).
The rare Ins/Ins genotype was present in only 9.7% of
controls and 4% of cases. The homozygous Del genotype
was significantly higher in the cases than in controls (P =Figure 3 Partial sequence electropherogram of 3'-UTR Del/Ins polymo0.003). Frequency of Del allele was 0.75and 0.66, while as
the frequency of Ins allele was 0.24 and 0.34 in cases and
controls respectively (OR: 0.62, 95% CI: 0.48-0.78). The
frequency of Del allele correlated directly with the risk fac-
tors and the severity of disease as shown by the intra-
group genotype analysis (Table 2). Among the cases, there
was a significant association between the presence of Del
allele and various risk factors. Del allele was observed to
be directly associated with elevated BMI, WHR and total
cholesterol. Although fasting and post-prandial glucose
levels didn’t vary significantly across Del and Ins geno-
types, association of HbA1c levels were statistically signifi-
cant. This can be due to disparity in the glycemic
variability or underlying poor control over longer dur-
ation. The glycemic control of the studied population is a
major reason for extensive difference between plasma glu-
cose and HbA1c levels. Systemic examination of subjects
showed that the carriers of Del allele were primarily
hypertensive. Higher incidence of Ins allele in the control
population is reminiscent of its protective role against the
risk factors of T2DM in our population. The intra-group
genotyping analysis in controls showed a linear association
of the risk factors with the three genotypes: Del/Del, Del/
Ins and Ins/Ins. Del allele was associated with atypical
profile of various risk factors that play a role in predispos-
ing the carriers of Del allele to T2DM whereas the Ins al-
lele exhibited classic values for the same in the control
population.
Discussion
The risk of developing diabetes and related metabolic
abnormalities is high in Asian Indians as compared torphism of LEPR gene (Heterozygous Del/Ins).
Table 1 Genotype analysis and Allele frequency of 3'-UTR Del/Ins polymorphism in LEPR gene
LEPR 3'-UTR CTTTA polymorphism T2DM cases Controls OR (95% CI) χ2 P value
Genotypes n % n %
DD# 178/320 55.6 146/350 41.7
DI 129/320 40.4 170/350 48.6 0.62 8.65 0.003
(0.45-0.85)
II 13/320 4 34/350 9.7 0.31 12.23 0.0004
(0.15-0.61)
DI+ II 142/320 44.37 204/350 58.28 0.57 12.95 0.0003
(0.42-0.77)
Alleles
Del 485/640 75.78 462/700 66 0.62 15.43 0.00011
Ins 155/640 24.21 238/700 34 (0.48-0.78)
Chi-square analysis is used for genotyping analysis where P value of <0.05 at 95% confidence interval was considered to be significant.
DD: Deletion/Deletion, DI: Deletion/Insertion, II: Insertion/Insertion.
#Reference genotype.
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genetic factors determining body fat distribution and
glucose metabolism. Distinctive features of “Asian Indian
phenotype” include major risk factors responsible for in-
creased predilection towards type 2 diabetes [23-27]. In-
creased level of adipokines that promote insulin resistance
is also an underlying biochemical risk factor [28]. The
variance in prevalence rates for different ethnic popula-
tions substantiates the evidence for a genetic component
involved in the development of T2DM. However, non-
genetic factors such as environmental and culturalTable 2 Genotypic correlation of 3'-UTR Del/Ins
polymorphism of LEPR gene with various clinical and
laboratory features among the study population
Parameter Del/Del Del/Ins + Ins/Ins P value
Age (years) 50.7 ± 10.7 49.0 ± 12.6 0.06
BMI (kg/m2) 25.0 ± 5.4 23.4 ± 2.6 0.005
WHR 0.92 ± 0.10 0.88 ± 0.09 0.010
BP (Systolic) 140.5 ± 20.7 130.9 ± 18.4 0.003
BP (Diastolic) 83.0 ± 10.4 81.1 ± 9.6 0.242
BG-F (mg/dl) 212.7 ± 91.4 200.1 ± 43.9 0.183
BG-PP (mg/dl) 303.1 ± 121.7 287.6 ± 62.0 0.230
HbA1c (%) 9.4 ± 2.5 8.6 ± 1.1 0.002
TGs (mg/dl) 225.7 ± 128.6 205.0 ± 43.9 0.082
LDL (mg/dl) 108.8 ± 27.1 103.3 ± 18.9 0.172
HDL (mg/dl) 41.3 ± 9.7 40.3 ± 7.5 0.494
Chol (mg/dl) 182.1 ± 37.7 170.2 ± 32.6 0.041
BMI: Body Mass Index, WHR: Waist to Hip ratio, BP: Blood Pressure, BG-F: Blood
Glucose Fasting, BG-PP: Blood Glucose Post Prandial, TGs: Triglycerides, LDL: Low
Density Lipoproteins, HDL: High Density Lipoproteins, Chol: Cholesterol.
(Data expressed as Mean ± SD, Non metric data was analyzed by Mann
Whitney-U test, P value for inter group variants measured by Student’s t-test at
95% confidence interval).influences can be moderately ascribed to ethnic variability.
Studies have shown that while some genes seem to confer
increased susceptibility to diabetes in Indians [29,30];
some protective genes in Europeans do not appear to pro-
tect Indians [31]. Kashmir valley is an ethnic region situ-
ated in the north India. Very few studies highlighting the
prevalence of type 2 diabetes in this region have been
undertaken [32,33]. The population also exhibits high fre-
quency of undiagnosed diabetes [32]. Lately an increased
trend in the rate of T2DM along with a high prevalence of
impaired fasting glycaemia (IFG) especially in young
adults was observed [33]. Although the socio-geographic
features of this population like being a distinct, cut-off
valley from other states and highly endogamous and
consanguineous marriages practised here, the place of-
fers an interesting and potential population for conducting
genetic studies. However, studies exploring the genetic
variations or molecular mechanisms involved in the etio-
pathogenesis of type 2 diabetes are even meagre for this
population [34,35].
The foremost advances linking the genetic basis of
T2DM has amassed around 40 predisposing loci [3]. A
number of sequence determinants are known to affect
mammalian mRNA abundance [36]. Occurrence of mul-
tiple copies of the core sequence UUAUUUA(U/A)(U/A),
designated as the A +U destabilizing element (AUDE), is
known to destabilize a variety of mRNA species [37]. A
closely reminiscent sequence of 5'-UACUUUAUA-3' is
created in the 3'-UTR of the insertion allele. The presence
of extra C in this sequence could probably eliminate the
destabilizing effect of the core sequence, nonetheless its
role is not identified [17]. The 3'-UTR of LEPR gene har-
bors a pentanucleotide Del/Ins polymorphism that pro-
duces an AU-rich sequence capable of affecting the
mRNA stability by creating a stem-loop structure [22].
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bility is not completely understood though in many cases
these motifs have been shown to bind to regulatory pro-
teins, which in turn could affect the rate of degradation
and/or translation of mRNA [36,38].
We undertook this study to elucidate the role of
CTTTA pentanucleotide Del/Ins polymorphism in LEPR
gene in ethnic Kashmiri population. In our population
frequency of Del allele was 75.78% and 66% and fre-
quency of Ins allele was 24.21% and 34% in cases and
controls respectively. The genotypes for this polymorph-
ism were in Hardy Weinberg equilibrium for both cases
and controls. In our study, Del allele showed a linear as-
sociation with the prevalence of diabetes as well as with
the associated risk factors. According to our observa-
tions, Ins allele conferred a protective effect against the
development of T2DM. The genotype and allele fre-
quency of this polymorphism in our population is com-
parable to another study in which the carriers of the
insertion allele had a 79% reduced risk of T2DM com-
pared with non-carriers in the 4-year follow-up [19]. The
Del/Ins variant has been found to be associated with
serum insulin levels [17,19], serum high density lipopro-
tein (HDL)-cholesterol and apolipoprotein A (apo A)-I
levels [20], and susceptibility to T2DM [20-22]. In our
study the intra group genotyping among both cases and
controls explicated a positive correlation between the Del
allele and the imperative risk factors that predispose our
population to T2DM. Our study attests the salvage role of
the Ins allele against the predilection and occurrence of
T2DM in our population. The elusive factors of relatively
higher proportion of IFG in Kashmiri population [32,33]
and the overweight-obesity endemic [39] can in part be
explained at the molecular level by the prevalence of a
genotypic risk factor (Del allele) that might play a role in
inflection and predisposition of its carriers to the T2DM.
However other genetic factors may modulate this effect in
cumulative or independent manner. The elucidation of
these factors in larger samples from our population
may substantiate the role of pertinent molecular and
genetic factors involved in the pathogenesis and pro-
gression to T2DM. This study and its findings may be
useful and provide some basic information regarding
our understanding of multifaceted pathological inter-
connections between metabolic legacy, genetic predis-
position and contemporary surroundings.Competing interests
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